Some of the major players operating in the global enrofloxacin market are Bayer Corporation, KRKA dd, Novo mesto, Pro Zoon, Chanelle Pharmaceuticals, VetMedic and VM Pharma.
The global enrofloxacin market size is expected to witness potential gains in the future and register a significant CAGR during the forecast period (2019 – 2027).
Download the PDF brochure of the research report @ https://www.coherentmarketinsights.com/insight/request-pdf/2742
Enrofloxacin (ENR) is a fluoroquinolone antibiotic and a veterinary antibacterial agent. It is sold under the trade name Baytril by Bayer Corporation. ENR is currently approved for the treatment of pets and domestic animals in the United States by the United States Food and Drug Administration (FDA). ENR is effective against several gram-positive and gram-negative bacteria such as Pseudomonas aeruginosa, Klebsiella, and E. coli. It is used for the treatment of skin and soft tissue infections, urinary tract infections in dogs and cats, Chlamydophila felis infections in cats, and ulcerative colitis caused by Escherichia coli in dogs. Significant growth of the poultry industry is expected to positively impact the growth of the enrofloxacin market during the forecast period.
The increasing use of ENR in the treatment of infections caused by both Gram-negative and Gram-positive bacteria is expected to drive the market growth. ENR is administered to cattle by subcutaneous injection and to pigs by intramuscular injection. It is administered orally to cattle, pigs, turkeys and chickens for the treatment of respiratory and food infections.
However, in rare cases, the use of ENR in cats has been associated with retinal toxicity. The drug cannot be used in animals that are allergic to it. ENR is also associated with some side effects such as vomiting, diarrhea, and poor appetite. In addition, effective September 2005, enrofloxacin was withdrawn from US poultry farms. These factors are expected to hamper the growth of the enrofloxacin market during the forecast period.
The growing trend of adopting pets is expected to provide lucrative opportunities for market players to increase their market share.
Browse the research report at: https://www.coherentmarketinsights.com/ongoing-insight/enrofloxacin-market-2742
Asia-Pacific is expected to hold a dominant position in the enrofloxacin market during the forecast period. Factors such as population growth and high demand for poultry meat are expected to impact the growth of the market. Moreover, the significant growth of the pet industry in China is also expected to contribute to the growth of the market in Asia-Pacific. Restrictions on the use of ENR in the United States are expected to negatively affect market growth in North America.
About Coherent Market Insights:
Coherent Market Insights is a leading market research and consulting firm providing action-ready syndicated research reports, personalized market analysis, advisory services and competitive analysis through various recommendations related to emerging market trends , technologies and potential opportunities in absolute dollars.
Name: Mr. Raj Shah
Telephone: we +12067016702 / UK +4402081334027